{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T21:55:14Z","timestamp":1673301314139},"reference-count":30,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genet. Mol. Biol."],"DOI":"10.1590\/s1415-47572011005000025","type":"journal-article","created":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T10:35:45Z","timestamp":1311330945000},"page":"410-415","source":"Crossref","is-referenced-by-count":4,"title":["Mucopolysaccharidoses in northern Brazil: Targeted mutation screening and urinary glycosaminoglycan excretion in patients undergoing enzyme replacement therapy"],"prefix":"10.1590","volume":"34","author":[{"given":"Gustavo M.","family":"Viana","sequence":"first","affiliation":[{"name":"Universidade Federal do Par\u00e1, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nath\u00e1lia O. de","family":"Lima","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosely","family":"Cavaleiro","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Alves","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel C.N.","family":"Souza","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimunda","family":"Feio","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Leistner-Segal","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Cl\u00ednicas de Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul, Brazil; Hospital de Cl\u00ednicas de Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz C. Santana da","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2011,7,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10545-006-0403-z","article-title":"Molecular characterization of Portuguese patients with mucopolysaccharidosis type II shows evidence that the IDS gene is prone to splicing mutations","volume":"29","author":"Alves S","year":"2006","journal-title":"J Inherit Metab Dis","ISSN":"http:\/\/id.crossref.org\/issn\/0141-8955","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10545-007-0551-9","article-title":"Enzyme replacement therapy in 12 patients with MPS I-H\/S with homozygous p","volume":"30","author":"Arora RS","year":"2007","journal-title":"Leu490Pro mutation. J Inherit Metab Dis"},{"key":"ref3","first-page":"23","article-title":"Estimativa do perfil epidemiol\u00f3gico de Mucopolissacaridoses no Estado do Par\u00e1","volume":"43","author":"Castro N","year":"2007","journal-title":"Pediatria Moderna","ISSN":"http:\/\/id.crossref.org\/issn\/0031-3920","issn-type":"print"},{"key":"ref4","first-page":"667","article-title":"Laronidase for treating mucopolysaccharidosis type I","volume":"6","author":"El Dib RP","year":"2007","journal-title":"Genet Mol Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1651-2227.2007.00213.x","article-title":"Mucopolysaccharidosis type II: An update on mutation spectrum","volume":"96","author":"Froissart R","year":"2007","journal-title":"Acta Paediatr Supp"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1023\/A:1005323918923","article-title":"Mutations among Italian mucopolysaccharidosis type I patients","volume":"20","author":"Gatti R","year":"1997","journal-title":"J Inherit Metab Dis","ISSN":"http:\/\/id.crossref.org\/issn\/0141-8955","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1542\/peds.2004-1023","article-title":"Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): Results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"115","author":"Harmatz P","year":"2005","journal-title":"Pediatrics","ISSN":"http:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ymgme.2008.04.001","article-title":"Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"94","author":"Harmatz P","year":"2008","journal-title":"Mol Genet Metab","ISSN":"http:\/\/id.crossref.org\/issn\/1096-7192","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1023\/A:1005363414792","article-title":"Mutation analysis in the iduronate-2-sulphatase gene in 43 Japanese patients with mucopolysaccharidosis type II (Hunter disease)","volume":"21","author":"Isogai K","year":"1998","journal-title":"J Inherit Metab Dis","ISSN":"http:\/\/id.crossref.org\/issn\/0141-8955","issn-type":"print"},{"key":"ref10","first-page":"597","article-title":"Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted interpretation: Toward mutation mapping of the iduronate2-sulfatase gene","volume":"56","author":"Jonsson JJ","year":"1995","journal-title":"Am J Hum Genet","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9297","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/humu.10313","article-title":"Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy","volume":"23","author":"Karageorgos L","year":"2004","journal-title":"Hum Mutat","ISSN":"http:\/\/id.crossref.org\/issn\/1059-7794","issn-type":"print"},{"key":"ref12","first-page":"21","article-title":"Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome)","volume":"36","author":"Li P","year":"1999","journal-title":"J Med Genet","ISSN":"http:\/\/id.crossref.org\/issn\/0022-2593","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2006.01.001","article-title":"Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: Biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers","volume":"369","author":"Lin SP","year":"2006","journal-title":"Clin Chim Acta","ISSN":"http:\/\/id.crossref.org\/issn\/0009-8981","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1399-0004.2007.00951.x","article-title":"Molecular analysis of mucopolysaccharidosis type IIIB in Portugal: Evidence of a single origin for a common mutation (R234C) in the Iberian Peninsula","volume":"73","author":"Mangas M","year":"2008","journal-title":"Clin Genet","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9163","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1096-8628(20000117)90:2<108::AID-AJMG3>3.0.CO;2-Y","article-title":"Unique frequency of known mutations in Brazilian MPS I patients","volume":"90","author":"Matte U","year":"2000","journal-title":"Am J Med Genet","ISSN":"http:\/\/id.crossref.org\/issn\/0148-7299","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1096-7192(02)00200-7","article-title":"Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients","volume":"78","author":"Matte U","year":"2003","journal-title":"Mol Genet Metab","ISSN":"http:\/\/id.crossref.org\/issn\/1096-7192","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle PJ","year":"1999","journal-title":"JAMA","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/08035320510028120","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type I","volume":"94","author":"Miebach E","year":"2005","journal-title":"Acta Paediatr Suppl","ISSN":"http:\/\/id.crossref.org\/issn\/0803-5326","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The mucopolysaccharidoses: A heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer J","year":"2004","journal-title":"J Pediatr","ISSN":"http:\/\/id.crossref.org\/issn\/0022-3476","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: Management and treatment guidelines","volume":"123","author":"Muenzer J","year":"2009","journal-title":"Pediatrics","ISSN":"http:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref21","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"pp 3421","volume-title":"The mucopolysaccharidoses","author":"Neufeld EF","year":"2001"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10545-005-0020-2","article-title":"Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients","volume":"28","author":"Petry MF","year":"2005","journal-title":"J Inherit Metab Dis","ISSN":"http:\/\/id.crossref.org\/issn\/0141-8955","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00417-008-1030-1","article-title":"Does enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis?","volume":"247","author":"Pitz S","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol","ISSN":"http:\/\/id.crossref.org\/issn\/0721-832X","issn-type":"print"},{"key":"ref24","series-title":"Molecular Cloning -A Laboratory Manual","author":"Sambrook J","year":"2001","edition":"3"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","article-title":"A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years","volume":"90","author":"Sifuentes M","year":"2007","journal-title":"Mol Genet Metab","ISSN":"http:\/\/id.crossref.org\/issn\/1096-7192","issn-type":"print"},{"key":"ref26","author":"Solyom E","year":"1996"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/humu.9051","article-title":"Molecular analysis of 30 mucopolysaccharidosis type I patients: Evaluation of the mutational spectrum in Italian population and identification of 13 novel mutations","volume":"20","author":"Venturi N","year":"2002","journal-title":"Hum Mutat","ISSN":"http:\/\/id.crossref.org\/issn\/1059-7794","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/clinchem\/35.3.374","article-title":"Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion","volume":"35","author":"Whitley CB","year":"1989","journal-title":"Clin Chem","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9147","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: A randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"144","author":"Wraith JE","year":"2004","journal-title":"J Pediatr","ISSN":"http:\/\/id.crossref.org\/issn\/0022-3476","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: Results of a multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"120","author":"Wraith JE","year":"2007","journal-title":"Pediatrics","ISSN":"http:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"}],"container-title":["Genetics and Molecular Biology"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/gmb\/v34n3\/2010-254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T14:06:18Z","timestamp":1592748378000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1415-47572011000300007&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,22]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011]]}},"alternative-id":["S1415-47572011000300007"],"URL":"https:\/\/doi.org\/10.1590\/s1415-47572011005000025","relation":{},"ISSN":["1678-4685","1415-4757"],"issn-type":[{"value":"1678-4685","type":"electronic"},{"value":"1415-4757","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,22]]}}}